Robin Adelstein, former North American General Counsel of Sandoz, the generics division of Novartis, has joined Norton Rose Fulbright’s New York office as a partner. With more than 25 years of in-house and private practice experience at Novartis, one of the world’s largest healthcare companies, and Diageo, a global leader in premium drinks, Robin’s pharmaceutical industry background and in-house experience are exceptional. She has represented clients in government enforcement actions by the Federal Trade Commission, the Department of Justice, the Department of Health and Human Services Office of the Inspector General and State Attorneys General. She also is known for her antitrust expertise, having advised clients with respect to issues arising in mergers and acquisitions, joint ventures, trade association activities, distribution practices, pricing programs and other aspects of competitor and customer communications and associations.
